Secondary Spontaneous Pneumothorax

Overview


Plain-Language Overview

Secondary Spontaneous Pneumothorax is a condition where air leaks into the space between the lung and chest wall, causing the lung to collapse. It affects the respiratory system and usually occurs in people with underlying lung diseases such as chronic obstructive pulmonary disease (COPD) or cystic fibrosis. This air leak can cause sudden chest pain and difficulty breathing. The condition can reduce the lung's ability to expand, leading to decreased oxygen levels in the blood. It is more serious than a primary spontaneous pneumothorax because it happens in already weakened lungs. Prompt medical evaluation is important to assess the severity and guide treatment.

Clinical Definition

Secondary Spontaneous Pneumothorax (SSP) is defined as the presence of air in the pleural space causing partial or complete lung collapse in patients with preexisting pulmonary pathology. It commonly results from rupture of subpleural blebs or bullae in diseases such as COPD, interstitial lung disease, or infections like pneumocystis pneumonia. The underlying lung disease compromises alveolar integrity, increasing the risk of pleural air leakage. SSP is clinically significant due to its association with more severe respiratory compromise and higher risk of complications compared to primary spontaneous pneumothorax. Patients often present with acute dyspnea, pleuritic chest pain, and signs of respiratory distress. Radiographic evidence of lung collapse with underlying lung abnormalities confirms the diagnosis.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.